Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Short Description: Dolasetron mesylate oral
Coverage Code: Special coverage instructions apply
Action Code: No maintenance for this code
Date Added: April 1, 1998
Effective Date: April 1, 1998
Termination Date: